| 0 |
VIRAL CORNEAL ULCER |
1 |
0.0909 |
| 1 |
BIOPSY UTERUS ABNORMAL |
1 |
0.0769 |
| 2 |
PATIENT DISSATISFACTION WITH TREATMENT |
105 |
0.0544 |
| 3 |
ALLERGY TEST |
1 |
0.0526 |
| 4 |
LID LAG |
3 |
0.0429 |
| 5 |
DRUG EFFECT LESS THAN EXPECTED |
469 |
0.0316 |
| 6 |
MEPHISTO SIGN |
2 |
0.0282 |
| 7 |
BROW PTOSIS |
14 |
0.0213 |
| 8 |
REDUCED FACIAL EXPRESSION |
17 |
0.0167 |
| 9 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
715 |
0.0159 |
| 10 |
DERMATOCHALASIS |
2 |
0.0136 |
| 11 |
ADMINISTRATION SITE WARMTH |
1 |
0.0122 |
| 12 |
PROGNATHISM |
1 |
0.0106 |
| 13 |
FACIAL ASYMMETRY |
10 |
0.0105 |
| 14 |
PRODUCT PREPARATION ISSUE |
59 |
0.0090 |
| 15 |
EYELID PTOSIS |
73 |
0.0072 |
| 16 |
EAR, NOSE AND THROAT DISORDER |
1 |
0.0071 |
| 17 |
INJECTION SITE PAPULE |
28 |
0.0061 |
| 18 |
EUSTACHIAN TUBE OBSTRUCTION |
1 |
0.0061 |
| 19 |
INJECTION SITE PUSTULE |
2 |
0.0052 |
| 20 |
INJECTION SITE ECZEMA |
1 |
0.0052 |
| 21 |
EXTRAOCULAR MUSCLE PARESIS |
2 |
0.0044 |
| 22 |
SKIN INDENTATION |
2 |
0.0042 |
| 23 |
INJECTION SITE GRANULOMA |
1 |
0.0042 |
| 24 |
APPLICATION SITE ACNE |
2 |
0.0041 |
| 25 |
FACIAL NEURALGIA |
1 |
0.0038 |
| 26 |
CONJUNCTIVITIS VIRAL |
1 |
0.0038 |
| 27 |
PERIORBITAL SWELLING |
20 |
0.0035 |
| 28 |
INJECTION SITE OEDEMA |
6 |
0.0035 |
| 29 |
MUSCLE HYPERTROPHY |
1 |
0.0028 |
| 30 |
NEUROMUSCULAR TOXICITY |
1 |
0.0028 |
| 31 |
FACIAL DISCOMFORT |
2 |
0.0028 |
| 32 |
INJECTION SITE HYPOAESTHESIA |
4 |
0.0028 |
| 33 |
NASAL TURBINATE HYPERTROPHY |
1 |
0.0027 |
| 34 |
THERAPEUTIC RESPONSE DELAYED |
7 |
0.0025 |
| 35 |
SKIN LAXITY |
1 |
0.0023 |
| 36 |
FACIAL NERVE DISORDER |
1 |
0.0023 |
| 37 |
SKIN WRINKLING |
6 |
0.0022 |
| 38 |
MASTOCYTOSIS |
1 |
0.0021 |
| 39 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 40 |
INJECTION SITE INFLAMMATION |
10 |
0.0020 |
| 41 |
SWELLING OF EYELID |
12 |
0.0019 |
| 42 |
OCCIPITAL NEURALGIA |
1 |
0.0018 |
| 43 |
SOFT TISSUE SWELLING |
1 |
0.0018 |
| 44 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
8 |
0.0018 |
| 45 |
OFF LABEL USE |
1315 |
0.0015 |
| 46 |
INJECTION SITE PARAESTHESIA |
2 |
0.0013 |
| 47 |
INJECTION SITE SWELLING |
99 |
0.0013 |
| 48 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 49 |
PHARYNGEAL PARAESTHESIA |
2 |
0.0013 |
| 50 |
DRUG INEFFECTIVE |
1590 |
0.0012 |
| 51 |
EYELID IRRITATION |
3 |
0.0012 |
| 52 |
PERIORBITAL PAIN |
1 |
0.0012 |
| 53 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 54 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 55 |
BIOPSY |
1 |
0.0011 |
| 56 |
INJECTION SITE ULCER |
1 |
0.0011 |
| 57 |
APPLICATION SITE BRUISE |
1 |
0.0010 |
| 58 |
EYELID RASH |
1 |
0.0010 |
| 59 |
EYELIDS PRURITUS |
3 |
0.0010 |
| 60 |
INJECTION SITE HYPERSENSITIVITY |
3 |
0.0010 |
| 61 |
EYE CONTUSION |
2 |
0.0009 |
| 62 |
INJECTION SITE IRRITATION |
12 |
0.0009 |
| 63 |
EYELID DISORDER |
2 |
0.0009 |
| 64 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
1 |
0.0009 |
| 65 |
SINUS PAIN |
2 |
0.0009 |
| 66 |
INJECTION SITE DISCOMFORT |
9 |
0.0009 |
| 67 |
INJECTION SITE VESICLES |
5 |
0.0008 |
| 68 |
INJECTION SITE PRURITUS |
52 |
0.0008 |
| 69 |
DACRYOSTENOSIS ACQUIRED |
1 |
0.0008 |
| 70 |
COUNTERFEIT PRODUCT ADMINISTERED |
1 |
0.0008 |
| 71 |
LIP EXFOLIATION |
1 |
0.0008 |
| 72 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 73 |
OFF LABEL USE OF DEVICE |
1 |
0.0007 |
| 74 |
MUSCLE TWITCHING |
17 |
0.0007 |
| 75 |
LIP PAIN |
2 |
0.0007 |
| 76 |
EYELID OEDEMA |
8 |
0.0007 |
| 77 |
ACNE CYSTIC |
2 |
0.0007 |
| 78 |
INJECTION SITE NODULE |
7 |
0.0006 |
| 79 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 80 |
MEDICAL PROCEDURE |
1 |
0.0006 |
| 81 |
LOWER RESPIRATORY TRACT CONGESTION |
1 |
0.0006 |
| 82 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
3 |
0.0006 |
| 83 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 84 |
VERTIGO POSITIONAL |
1 |
0.0006 |
| 85 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 86 |
FACIAL PAIN |
5 |
0.0006 |
| 87 |
TETANY |
1 |
0.0005 |
| 88 |
ASTHENOPIA |
3 |
0.0005 |
| 89 |
INJECTION SITE MASS |
20 |
0.0005 |
| 90 |
INJECTION SITE ERYTHEMA |
67 |
0.0005 |
| 91 |
LIP DISORDER |
1 |
0.0005 |
| 92 |
DIPLOPIA |
13 |
0.0005 |
| 93 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 94 |
EYELID PAIN |
1 |
0.0005 |
| 95 |
BLEPHAROSPASM |
3 |
0.0005 |
| 96 |
INJECTION SITE INDENTATION |
1 |
0.0005 |
| 97 |
EYE SWELLING |
17 |
0.0005 |
| 98 |
INJECTION SITE RASH |
14 |
0.0005 |
| 99 |
PRODUCT STORAGE ERROR |
39 |
0.0004 |
| 100 |
VITILIGO |
1 |
0.0004 |
| 101 |
PAPULE |
3 |
0.0004 |
| 102 |
SKIN TIGHTNESS |
2 |
0.0004 |
| 103 |
BREATH ODOUR |
1 |
0.0004 |
| 104 |
EYE OEDEMA |
1 |
0.0004 |
| 105 |
INJECTION SITE DISCOLOURATION |
5 |
0.0004 |
| 106 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
72 |
0.0004 |
| 107 |
OSTEITIS |
1 |
0.0004 |
| 108 |
LABYRINTHITIS |
1 |
0.0004 |
| 109 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 110 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 111 |
INJECTION SITE PAIN |
114 |
0.0004 |
| 112 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 113 |
VERTIGO |
22 |
0.0004 |
| 114 |
ELECTRIC SHOCK SENSATION |
1 |
0.0004 |
| 115 |
FACIAL PARALYSIS |
3 |
0.0004 |
| 116 |
HYPOAESTHESIA ORAL |
5 |
0.0003 |
| 117 |
KERATITIS |
1 |
0.0003 |
| 118 |
VISION BLURRED |
43 |
0.0003 |
| 119 |
SWELLING FACE |
20 |
0.0003 |
| 120 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 121 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 122 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 123 |
INJECTION SITE WARMTH |
6 |
0.0003 |
| 124 |
FACIAL PARESIS |
1 |
0.0003 |
| 125 |
HEAD DISCOMFORT |
5 |
0.0003 |
| 126 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 127 |
PANIC REACTION |
2 |
0.0003 |
| 128 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
15 |
0.0003 |
| 129 |
HEADACHE |
171 |
0.0003 |
| 130 |
OCULAR DISCOMFORT |
3 |
0.0003 |
| 131 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
19 |
0.0003 |
| 132 |
PHOTOPHOBIA |
5 |
0.0003 |
| 133 |
LACRIMATION INCREASED |
8 |
0.0003 |
| 134 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 135 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 136 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 137 |
BRAIN FOG |
4 |
0.0003 |
| 138 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 139 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 140 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 141 |
MUSCLE TIGHTNESS |
4 |
0.0002 |
| 142 |
SWELLING |
23 |
0.0002 |
| 143 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 144 |
TEARFULNESS |
1 |
0.0002 |
| 145 |
HORDEOLUM |
1 |
0.0002 |
| 146 |
INJECTION SITE BRUISING |
18 |
0.0002 |
| 147 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 148 |
DRY EYE |
11 |
0.0002 |
| 149 |
DEFORMITY |
2 |
0.0002 |
| 150 |
PAIN IN JAW |
6 |
0.0002 |
| 151 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 152 |
VITREOUS FLOATERS |
2 |
0.0002 |
| 153 |
DYSPHAGIA |
19 |
0.0002 |
| 154 |
BURNING SENSATION |
14 |
0.0002 |
| 155 |
TRISMUS |
1 |
0.0002 |
| 156 |
TENDERNESS |
2 |
0.0002 |
| 157 |
CHEILITIS |
1 |
0.0002 |
| 158 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 159 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 160 |
CHOKING SENSATION |
1 |
0.0002 |
| 161 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 162 |
SKIN WARM |
1 |
0.0002 |
| 163 |
CATARACT OPERATION |
1 |
0.0002 |
| 164 |
NASAL DRYNESS |
1 |
0.0002 |
| 165 |
INTRAOCULAR PRESSURE INCREASED |
2 |
0.0002 |
| 166 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 167 |
EYE DISORDER |
5 |
0.0002 |
| 168 |
ADVERSE REACTION |
2 |
0.0002 |
| 169 |
SKIN MASS |
1 |
0.0001 |
| 170 |
SINUS CONGESTION |
2 |
0.0001 |
| 171 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 172 |
DISCOMFORT |
9 |
0.0001 |
| 173 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 174 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 175 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 176 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 177 |
DROOLING |
1 |
0.0001 |
| 178 |
MUSCULAR WEAKNESS |
16 |
0.0001 |
| 179 |
HYPOAESTHESIA |
21 |
0.0001 |
| 180 |
SENSITIVE SKIN |
1 |
0.0001 |
| 181 |
CONTUSION |
13 |
0.0001 |
| 182 |
URINARY INCONTINENCE |
4 |
0.0001 |
| 183 |
DISSOCIATION |
1 |
0.0001 |
| 184 |
APHTHOUS ULCER |
1 |
0.0001 |
| 185 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 186 |
GINGIVAL PAIN |
1 |
0.0001 |
| 187 |
MUSCLE DISORDER |
1 |
0.0001 |
| 188 |
PRESYNCOPE |
3 |
0.0001 |
| 189 |
HYPERAESTHESIA |
1 |
0.0001 |
| 190 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 191 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 192 |
LIP SWELLING |
4 |
0.0001 |
| 193 |
PALPITATIONS |
14 |
0.0001 |
| 194 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 195 |
SPEECH DISORDER |
6 |
0.0001 |
| 196 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 197 |
DRY MOUTH |
9 |
0.0001 |
| 198 |
TOOTHACHE |
2 |
0.0001 |
| 199 |
PANIC ATTACK |
4 |
0.0001 |
| 200 |
INFLUENZA LIKE ILLNESS |
9 |
0.0001 |
| 201 |
TINNITUS |
5 |
0.0001 |
| 202 |
HYPERSENSITIVITY |
20 |
0.0001 |
| 203 |
EYE PAIN |
6 |
0.0001 |
| 204 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 205 |
ERYTHEMA |
21 |
0.0001 |
| 206 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 207 |
FEELING HOT |
6 |
0.0001 |
| 208 |
EAR DISCOMFORT |
1 |
0.0001 |
| 209 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 210 |
PETECHIAE |
1 |
0.0001 |
| 211 |
ASPIRATION |
1 |
0.0001 |
| 212 |
DIZZINESS |
45 |
0.0001 |
| 213 |
NERVE INJURY |
1 |
0.0001 |
| 214 |
EYE PRURITUS |
3 |
0.0001 |
| 215 |
PARAESTHESIA |
14 |
0.0001 |
| 216 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 217 |
INJECTION SITE REACTION |
6 |
0.0001 |
| 218 |
DYSPHONIA |
5 |
0.0001 |
| 219 |
MIGRAINE |
8 |
0.0001 |
| 220 |
UNDERDOSE |
6 |
0.0001 |
| 221 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 222 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 223 |
PRODUCT COMPLAINT |
2 |
0.0001 |
| 224 |
MYDRIASIS |
1 |
0.0001 |
| 225 |
URTICARIA |
13 |
0.0001 |
| 226 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 227 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 228 |
MASS |
1 |
0.0001 |
| 229 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 230 |
EYE IRRITATION |
4 |
0.0001 |
| 231 |
HYPOKINESIA |
1 |
0.0001 |
| 232 |
THERAPEUTIC RESPONSE DECREASED |
4 |
0.0001 |
| 233 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 234 |
VISUAL IMPAIRMENT |
8 |
0.0001 |
| 235 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 236 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 237 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 238 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 239 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
0.0001 |
| 240 |
PRURITUS |
23 |
0.0001 |
| 241 |
FACE OEDEMA |
1 |
0.0001 |
| 242 |
SCAR |
1 |
0.0001 |
| 243 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 244 |
THIRST |
1 |
0.0001 |
| 245 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 246 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 247 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 248 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 249 |
RASH |
23 |
0.0001 |
| 250 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 251 |
ORAL HERPES |
1 |
0.0001 |
| 252 |
NASAL CONGESTION |
3 |
0.0001 |
| 253 |
SINUS DISORDER |
1 |
0.0001 |
| 254 |
HEART RATE INCREASED |
5 |
0.0001 |
| 255 |
SYNCOPE |
5 |
0.0000 |
| 256 |
TASTE DISORDER |
1 |
0.0000 |
| 257 |
FLUSHING |
5 |
0.0000 |
| 258 |
MUSCLE SPASMS |
9 |
0.0000 |
| 259 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 260 |
TACHYCARDIA |
4 |
0.0000 |
| 261 |
ORAL PAIN |
1 |
0.0000 |
| 262 |
THROAT IRRITATION |
2 |
0.0000 |
| 263 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 264 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 265 |
ANXIETY |
12 |
0.0000 |
| 266 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 267 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 268 |
FEELING ABNORMAL |
10 |
0.0000 |
| 269 |
AGEUSIA |
1 |
0.0000 |
| 270 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 271 |
JOINT STIFFNESS |
1 |
0.0000 |
| 272 |
PAIN |
23 |
0.0000 |
| 273 |
DYSPNOEA |
21 |
0.0000 |
| 274 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 275 |
LIMB INJURY |
1 |
0.0000 |
| 276 |
PALLOR |
1 |
0.0000 |
| 277 |
SKIN LESION |
1 |
0.0000 |
| 278 |
HERPES ZOSTER |
2 |
0.0000 |
| 279 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 280 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 281 |
CHEST PAIN |
6 |
0.0000 |
| 282 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 283 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 284 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 285 |
RHINORRHOEA |
2 |
0.0000 |
| 286 |
TREMOR |
5 |
0.0000 |
| 287 |
SKIN DISORDER |
1 |
0.0000 |
| 288 |
SINUSITIS |
3 |
0.0000 |
| 289 |
ASTHENIA |
11 |
0.0000 |
| 290 |
HEART RATE DECREASED |
1 |
0.0000 |
| 291 |
RESTLESSNESS |
1 |
0.0000 |
| 292 |
AGITATION |
2 |
0.0000 |
| 293 |
DYSARTHRIA |
1 |
0.0000 |
| 294 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 295 |
SEIZURE |
3 |
0.0000 |
| 296 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 297 |
NAUSEA |
19 |
0.0000 |
| 298 |
ANGIOEDEMA |
1 |
0.0000 |
| 299 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 300 |
ADVERSE EVENT |
2 |
0.0000 |
| 301 |
ARTHRALGIA |
9 |
0.0000 |
| 302 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 303 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 304 |
MALAISE |
9 |
0.0000 |
| 305 |
DYSPEPSIA |
2 |
0.0000 |
| 306 |
FLUID RETENTION |
1 |
0.0000 |
| 307 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 308 |
NERVOUSNESS |
1 |
0.0000 |
| 309 |
ECZEMA |
1 |
0.0000 |
| 310 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 311 |
RASH PRURITIC |
1 |
0.0000 |
| 312 |
OEDEMA |
1 |
0.0000 |
| 313 |
NECK PAIN |
1 |
0.0000 |
| 314 |
BLISTER |
1 |
0.0000 |
| 315 |
CHILLS |
2 |
0.0000 |
| 316 |
SURGERY |
1 |
0.0000 |
| 317 |
FATIGUE |
13 |
0.0000 |
| 318 |
STOMATITIS |
1 |
0.0000 |
| 319 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 320 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 321 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 322 |
HYPERHIDROSIS |
2 |
0.0000 |
| 323 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 324 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 325 |
PYREXIA |
5 |
0.0000 |
| 326 |
SLEEP DISORDER |
1 |
0.0000 |
| 327 |
HYPERTENSION |
3 |
0.0000 |
| 328 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 329 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 330 |
FALL |
4 |
0.0000 |
| 331 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 332 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 333 |
BALANCE DISORDER |
1 |
0.0000 |
| 334 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 335 |
COUGH |
3 |
0.0000 |
| 336 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 337 |
ALOPECIA |
2 |
0.0000 |
| 338 |
HAEMORRHAGE |
1 |
0.0000 |
| 339 |
CONSTIPATION |
2 |
0.0000 |
| 340 |
ASTHMA |
1 |
0.0000 |
| 341 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 342 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 343 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 344 |
BACK PAIN |
2 |
0.0000 |
| 345 |
VOMITING |
4 |
0.0000 |
| 346 |
JOINT SWELLING |
1 |
0.0000 |
| 347 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 348 |
INSOMNIA |
2 |
0.0000 |
| 349 |
WEIGHT DECREASED |
2 |
0.0000 |
| 350 |
INFECTION |
1 |
0.0000 |
| 351 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 352 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 353 |
MYALGIA |
1 |
0.0000 |
| 354 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 355 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 356 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 357 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 358 |
HYPOTENSION |
1 |
0.0000 |
| 359 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 360 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 361 |
DEPRESSION |
1 |
0.0000 |
| 362 |
DECREASED APPETITE |
1 |
0.0000 |
| 363 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 364 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 365 |
DIARRHOEA |
2 |
0.0000 |
| 366 |
PNEUMONIA |
1 |
0.0000 |